Administering a compound with known dopaminergic effects in the late afternoon or evening is a recipe for a sleepless night
Switch of NAD salvage to de novo biosynthesis sustains SIRT1-RelB-dependent inflammatory tolerance
Typical Clinical Ranges Loading Phase: 25 mg per week (subcutaneous injection) for 46 weeks Maintenance Phase: 2 mg every 12 weeks after the loading period Key Considerations Personalization: Dosage should be adjusted based on individual symptoms, sensitivities, and treatment response
DeRosier F, Hibbs C, Alessi K et al (2024) Progressive supranuclear palsy: neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies
However, it is important to note that weight gain can occur as a result of other factors such as a poor diet, lack of physical activity, hormonal imbalances, or certain medications